Floatz logo

tp53-epha-2-car-dc

TP53 R248Q

Chinese PLA General HospitalvaccinePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the TP53 R248Q cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Chinese PLA General Hospital
Phase 1CC

Same molecule, other indications

tp53-epha-2-car-dc is also rated in:

EphA2 OverexpressionDormant
CC
Indicative ·
43 / 100
View asset →
Li-Fraumeni syndromeDormant
CC
Indicative ·
43 / 100
View asset →
TP53 R175HDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →